Lipoxen is a leading UK based biopharmaceutical company providing specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a variety of important medical areas.
Working with some of the largest pharmaceutical organisations in the world, Lipoxen provides leading edge expertise in the development of a whole new generation of drugs and vaccines.
An advanced enabling technology that uses novel liposome based-constructs:
A portfolio with multi-billion dollar potential
Lipoxen's supergenerics product pipeline is based on its drug and vaccine delivery proprietary technologies. Our unique delivery technologies have the capacity to create new high-value, differentiated proprietary products. READ MORE...
The information in this website has been disclosed for the purposes of Rule 26 of the AIM Rules for companies (February 2007) and was last updated on 18 August 2008.